TradingChief.com: Group Board - @ALT ENERGY Alternative Energy

Stocks in @BIOTECH_PHARMA

ABII (Abraxis Bioscience Inc), ACOR (Acorda Therapeutics Inc.), ADS:CA (Adaltis Inc.), AEZ:CA (Aeterna Zentaris Inc.), AFFY (Affymax Inc.), AGEN (Antigenics Inc.), AHX:CA (Adherex Technologies Inc.), ALNY (Alnylam Pharmaceuticals Inc.), ALTU (Altus Pharmaceuticals Inc.), ALXN (Alexion Pharmaceuticals Inc.), AMB:CA (Ambrilia Biopharma Inc.), AMGN (Amgen Inc.), AMLN (Amylin Pharmaceuticals Inc.), ANP:CA (Angiotech Pharm), AOB (American Oriental Bioengineering Inc.), APH:CA (Alda Pharmaceuticals Corp.), ARIA (ARIAD Pharmaceuticals Inc.), AVI:CA (Advitech Inc.), AXP:CA (Axcan Pharma), BCRX (BioCryst Pharmaceuticals Inc.), BIIB (Biogen Idec Inc), BMRN (BioMarin Pharmaceutical Inc.), BNC:CA (Bioniche Life J), BPAX (Biosante Pharmaceuticals), BVF:CA (Biovail Corp), CADX (Cadence Pharmaceuticals Inc.), CDG:CA (Chondrogene Ltd.), CEGE (Cell Genesys Inc.), CELG (Celgene Corp.), CEPH (Cephalon Inc.), CERS (Cerus Corp.), CGRB (Cougar Biotechnology Inc.), CHTP (Chelsea Therapeutics International Ltd.), CLDA (Clinical Data Inc.), CNJ:CA (Cangene Corp), COM:CA (Cardiome Pharma Corp), CORI (Corillian Corp.), CRIS (Curis Inc.), CRXX (CombinatoRx Inc.), CTI:CA (Chemokine Therapeutics Corp.), CUR:CA (Diagnocure Inc J), CVTX (CV Therapeutics Inc.), CYPB (Cypress Bioscience Inc.), CYTK (Cytokinetics Inc.), CYTX (Cytori Therapeutics Inc), CZO:CA (Ceapro Inc), DDD:CA (Dragon Pharmaceutical Inc.), DDS:CA (Labopharm Inc), DND:CA (Cipher Pharmaceuticals Inc.), DNDN (Dendreon Corp.), DSCO (Discovery Laboratories Inc.), DYAX (Dyax Corp.), EBS (Emergent BioSolutions Inc.), EKO:CA (Noveko International Inc.), ELN (Elan Corp. plc), ENZN (Enzon Inc.), EURX (Eurand N.V.), EXEL (Exelixis Inc.), FMD.UN:CA (Futuremed Healthcare Income Fund), FMI:CA (Forbes MediTech), FOLD (Amicus Therapeutics Inc.), GAP:CA (Pharmagap Inc.), GENZ (Genzyme Corp.), GILD (Gilead Sciences Inc.), GNVC (GenVec Inc.), GTXI (GTx Inc.), HAE:CA (Haemacure Corp J), HALO (Halozyme Therapeutics Inc.), HBD:CA (COMEX Gold Bullion Bear), IBT:CA (Ibex Tech), IDEV (Indevus Pharmaceuticals Inc.), IDIX (Idenix Pharmaceuticals Inc.), ILMN (Illumina Inc.), IMGN (ImmunoGen Inc.), INCY (Incyte Corp.), ISA:CA (Isotechnika J), ISIS (Isis Pharmaceuticals Inc.), ITMN (InterMune Inc.), IZP:CA (Inflazyme Pharm), JAZZ (Jazz Pharmaceuticals Inc.), JEN:CA (The Jenex Corp.), LAB:CA (Lab International Inc), LBK:CA (Lifebank Corp.), LOR:CA (Lorus Therapeutics Inc.), LXRX (Lexicon Pharmaceuticals Inc.), MATK (Martek Biosciences Corp.), MAXY (Maxygen Inc.), MBC:CA (Millenium Biologix Corp.), MBX:CA (Microbix J), MDG:CA (Medicago Inc.), MDVN (Medivation Inc.), MEDX (Medarex Inc.), MGI:CA (Migenix Inc.), MIPI (Molecular Insight Pharmaceuticals Inc.), MIR:CA (Medmira Inc), MITI (Micromet Inc.), MNKD (MannKind Corp.), MNTA (Momenta Pharmaceuticals Inc.), MPH:CA (Medicure Inc), MRX (Medicis Pharmaceutical Corp.), MS:CA (Bioms Medical), MYG:CA (Methylgene Inc.), NABI (Nabi Biopharmaceuticals), NBIX (Neurocrine Biosciences Inc.), NCS:CA (Nucryst Pharmaceuticals Corp.), NPSP (NPS Pharmaceuticals Inc.), NRI:CA (Nuvo Research Inc.), NRM:CA (Neurochem), NTB:CA (Neptune Technologies & Bioressources Inc), NVAX (Novavax Inc.), OBP:CA (Ondine Biopharma Corp.), OMPI (Obagi Medical Products Inc.), ONC:CA (Oncolytics Bio), ONXX (ONYX Pharmaceuticals Inc.), OPTR (Optimer Pharmaceuticals Inc.), ORB:CA (Orbus Pharma Inc), OSIP (OSI Pharmaceuticals Inc.), OSIR (Osiris Therapeutics Inc.), PARD (Poniard Pharmaceuticals Inc.), PDLI (PDL BioPharma Inc.), PGNX (Progenics Pharmaceuticals Inc.), PLB:CA (Paladin Labs J), PLX (Protalix BioTherapeutics Inc), PMD:CA (Premd Inc.), PNO:CA (Prescient Neuropharma Inc), PTI:CA (Patheon Inc), QCOR (Questcor Pharmaceuticals), QGEN (Qiagen N.V.), QLT:CA (Qlt Inc), QLTI (QLT Inc.), QPT:CA (Quest Pharmatech Inc.), RBM:CA (Response Biomedical Corp.), REGN (Regeneron Pharmaceuticals Inc.), RGEN (Repligen Corp.), RPRX (Repros Therapeutics Inc.), RVX:CA (Resverlogix Corp.), SBS:CA (Sembiosys Genetics Inc.), SDI:CA (Spectral Diagnos), SEPR (Sepracor Inc.), SGEN (Seattle Genetics Inc.), SGMO (Sangamo BioSciences Inc.), SHH:CA (Sonomax Hearing Healthcare Inc.), SHQ:CA (Shire Acquisition Inc), SQNM (Sequenom Inc.), SSRX (3SBio Inc.), STEM (StemCells Inc.), SVA (Sinovac Biotech Ltd), SVNT (Savient Pharmaceuticals Inc), SXS:CA (Sentex Systems Ltd), TARG (Target Logistics Inc.), TCM (Tongjitang Chinese Medicines Company), TECH (Techne Corp.), TH:CA (Theratechnologies), THRX (Theravance Inc.), TMC:CA (Timbercreek Mtg Inv Corp), TRGT (Targacept Inc.), TTH:CA (Transition Therapeutics Inc.), UTHR (United Therapeutics Corp.), VAS:CA (Vasogen Inc), VICL (Vical Inc.), VIR:CA (Virexx Medical Corp.), VPHM (ViroPharma Inc.), VRTX (Vertex Pharmaceuticals Inc.), VSM:CA (Vsm Medtech Ltd.), WNX:CA (Warnex Inc.), WXI:CA (Wex Pharmaceuticals Inc.), XNPT (XenoPort Inc.), XOMA (XOMA Ltd.), YM:CA (Ym Biosciences Inc), ZGEN (ZymoGenetics Inc.)